311 related articles for article (PubMed ID: 17629751)
21. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
[TBL] [Abstract][Full Text] [Related]
22. Stage IB nonsmall cell lung cancers: are they all the same?
Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
[TBL] [Abstract][Full Text] [Related]
23. Symptomatic, stage IV, non-small-cell lung cancer (NSCLC): response, toxicity, performance status change and symptom relief in patients treated with cisplatin, vinblastine and mitomycin-C.
Tummarello D; Graziano F; Isidori P; Cellerino R
Cancer Chemother Pharmacol; 1995; 35(3):249-53. PubMed ID: 7528646
[TBL] [Abstract][Full Text] [Related]
24. Survival prediction and frequency of anticancer treatment in cancer patients hospitalized due to acute conditions. Role of clinical parameters and PaP score.
Numico G; Occelli M; Russi EG; Silvestris N; Pasero R; Fea E; Granetto C; Di Costanzo G; Colantonio I; Gasco M; Garrone O; Polla V; Merlano MC
Support Care Cancer; 2011 Nov; 19(11):1823-30. PubMed ID: 21560032
[TBL] [Abstract][Full Text] [Related]
25. Validation of the Modified Glasgow Prognostic Score in Advanced Cancer Patients Receiving Palliative Care.
Pantano Nde P; Paiva BS; Hui D; Paiva CE
J Pain Symptom Manage; 2016 Feb; 51(2):270-7. PubMed ID: 26598040
[TBL] [Abstract][Full Text] [Related]
26. Docetaxel as second-line chemotherapy for advanced non-small cell lung cancer.
Thongprasert S; Cheewakriangkrai R; Napapan S
J Med Assoc Thai; 2002 Dec; 85(12):1296-300. PubMed ID: 12678167
[TBL] [Abstract][Full Text] [Related]
27. Predictive factors for well-being in advanced cancer patients referred for palliative radiotherapy.
Lien K; Zeng L; Zhang L; Nguyen J; Di Giovanni J; Popovic M; Jamani R; Cramarossa G; Culleton S; Chow E
Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):443-51. PubMed ID: 22794326
[TBL] [Abstract][Full Text] [Related]
28. Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data.
Hoang T; Xu R; Schiller JH; Bonomi P; Johnson DH
J Clin Oncol; 2005 Jan; 23(1):175-83. PubMed ID: 15625371
[TBL] [Abstract][Full Text] [Related]
29. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
30. Clinical benefit in NSCLC: advanced-stage patients require symptom-improving palliation. Experiences from the 'Iressa' expanded access program.
Schütte W; Nagel S; Schaedlich S; Brust D; Blankenburg T
Onkologie; 2005 Apr; 28(4):195-8. PubMed ID: 15840967
[TBL] [Abstract][Full Text] [Related]
31. Edmonton symptom assessment scale: Italian validation in two palliative care settings.
Moro C; Brunelli C; Miccinesi G; Fallai M; Morino P; Piazza M; Labianca R; Ripamonti C
Support Care Cancer; 2006 Jan; 14(1):30-7. PubMed ID: 15937688
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy in elderly patients with advanced lung cancer. Part II: Treatment of non-small cell lung cancer (NSCLC).
Honecker F; Wedding U; Bokemeyer C;
Onkologie; 2004 Dec; 27(6):583-8. PubMed ID: 15591721
[TBL] [Abstract][Full Text] [Related]
33. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer.
Greer JA; Pirl WF; Jackson VA; Muzikansky A; Lennes IT; Heist RS; Gallagher ER; Temel JS
J Clin Oncol; 2012 Feb; 30(4):394-400. PubMed ID: 22203758
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a 'Watch and Wait' Approach for Chemotherapy in Patients with Newly Diagnosed Advanced Non-small Cell Lung Cancer from a Diverse Community Population.
Noonan K; Tong KM; Laskin J; Zheng YY; Melosky B; Sun S; Murray N; Ho C
Clin Oncol (R Coll Radiol); 2015 Sep; 27(9):505-13. PubMed ID: 26095646
[TBL] [Abstract][Full Text] [Related]
35. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care.
Pirovano M; Maltoni M; Nanni O; Marinari M; Indelli M; Zaninetta G; Petrella V; Barni S; Zecca E; Scarpi E; Labianca R; Amadori D; Luporini G
J Pain Symptom Manage; 1999 Apr; 17(4):231-9. PubMed ID: 10203875
[TBL] [Abstract][Full Text] [Related]
36. Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.
Ardizzoni A; Cafferata MA; Tiseo M; Filiberti R; Marroni P; Grossi F; Paganuzzi M
Cancer; 2006 Dec; 107(12):2842-9. PubMed ID: 17103443
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients.
Fiteni F; Vernerey D; Bonnetain F; Vaylet F; Sennélart H; Trédaniel J; Moro-Sibilot D; Herman D; Laizé H; Masson P; Derollez M; Clément-Duchêne C; Milleron B; Morin F; Zalcman G; Quoix E; Westeel V
Eur J Cancer; 2016 Jan; 52():120-8. PubMed ID: 26682871
[TBL] [Abstract][Full Text] [Related]
38. Prospective comparison of prognostic scores in palliative care cancer populations.
Maltoni M; Scarpi E; Pittureri C; Martini F; Montanari L; Amaducci E; Derni S; Fabbri L; Rosati M; Amadori D; Nanni O
Oncologist; 2012; 17(3):446-54. PubMed ID: 22379068
[TBL] [Abstract][Full Text] [Related]
39. Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
Berghmans T; Lafitte JJ; Thiriaux J; VanHoutte P; Lecomte J; Efremidis A; Koumakis G; Giner V; Richez M; Corhay JL; Wackenier P; Lothaire P; Mommen P; Ninane V; Sculier JP;
Lung Cancer; 2004 Sep; 45(3):339-48. PubMed ID: 15301874
[TBL] [Abstract][Full Text] [Related]
40. External Validation of a Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer.
Nieder C; Tollåli T; Haukland E; Reigstad A; Flatøy LR; Dalhaug A
Clin Lung Cancer; 2017 Jul; 18(4):e297-e301. PubMed ID: 28189593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
